Kids Menu

Covaxin for kids: SEC approves Bharat Biotech’s COVID vaccine for children from 2 to 18 yrs

Subject Expert Committee has approved Bharat Biotech’s covid vaccine ‘COVAXIN’ for children in the 2-18 age group. DCGI will now to take the final call. As part of the Phase II/III trial, the two-dose Covaxin was administered to 525 children 28 days apart. Bharat Biotech had received the drug regulators’ nod to conduct the children’s trial in May this year. Earlier the company had earlier indicated that if all goes well the vaccine for kids would be rolled out in October itself.

Read More

Related posts
Kids Menu

SA schools alert as kids mimic deadly Squid Game themes

Kids Menu

Our first time listening to Stray Kids "God's Menu (神메뉴)" - M/V Reaction

Kids Menu

It’s a Brave New World: FDA Approves Pfizer Vaccine for Little Kids

Kids Menu

FDA paves way for Pfizer COVID-19 vaccinations in young kids


Get exclusive recipes,
tips and more!

Leave a Reply

Your email address will not be published. Required fields are marked *